Ace2 Inhibitor Laboratories manufactures the ace2 inhibitor ovid 19 reagents distributed by Genprice. The Ace2 Inhibitor Ovid 19 reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact ACE2 Inhibitor. Other Ace2 products are available in stock. Specificity: Ace2 Category: Inhibitor Group: Ovid 19
Ovid 19 information
BTK inhibitor 19 |
T40185-10mg |
TargetMol Chemicals |
10mg |
Ask for price |
|
Description: BTK inhibitor 19 |
BTK inhibitor 19 |
T40185-1mg |
TargetMol Chemicals |
1mg |
Ask for price |
|
Description: BTK inhibitor 19 |
BTK inhibitor 19 |
T40185-50mg |
TargetMol Chemicals |
50mg |
Ask for price |
|
Description: BTK inhibitor 19 |
BTK inhibitor 19 |
T40185-5mg |
TargetMol Chemicals |
5mg |
Ask for price |
|
Description: BTK inhibitor 19 |
ATX inhibitor 19 |
T63904-10mg |
TargetMol Chemicals |
10mg |
Ask for price |
|
Description: ATX inhibitor 19 |
ATX inhibitor 19 |
T63904-1mg |
TargetMol Chemicals |
1mg |
Ask for price |
|
Description: ATX inhibitor 19 |
ATX inhibitor 19 |
T63904-50mg |
TargetMol Chemicals |
50mg |
Ask for price |
|
Description: ATX inhibitor 19 |
ATX inhibitor 19 |
T63904-5mg |
TargetMol Chemicals |
5mg |
Ask for price |
|
Description: ATX inhibitor 19 |
BTK inhibitor 19 |
MBS5800472-5mg |
MyBiosource |
5(mg |
EUR 915 |
BTK inhibitor 19 |
MBS5800472-5x5mg |
MyBiosource |
5x5(mg |
EUR 3970 |
BTK inhibitor 19 |
HY-139881 |
MedChemExpress |
Get quote |
Ask for price |
Description: BTK inhibitor 19 is a highly selective, covalent BTK inhibitor (IC50 = 2.7 nM). |
ATX inhibitor 19 |
HY-146122 |
MedChemExpress |
Get quote |
Ask for price |
Description: ATX inhibitor 19 (compound 22) is a potent ATX (autotaxin) inhibitor, with an IC50 of 156 nM[1]. |
ACE2:Spike RBD (SARS-CoV-2) Inhibitor Screening Colorimetric Assay Kit |
78031 |
BPS Bioscience |
96 rxns. |
EUR 630 |
Description: Coronavirus disease 2019 (COVID-19) increases the risk of developing Acute Respiratory Distress Syndrome (ARDS), which is often fatal at the late stages of the infection when the SAR-CoV-2 virus causes significant damage to the lungs. As a first step of the viral replication strategy, the virus attaches to the host cell surface before entering the cell. The Spike protein receptor binding domain (RBD) recognizes and attaches to the Angiotensin-Converting Enzyme 2 (ACE2) receptor found on the surface of type I and II pneumocytes, endothelial cells, and ciliated bronchial epithelial cells. Drugs targeting the interaction between the Spike protein of SARS-CoV-2 and ACE2 may offer some protection against the viral infection.The ACE2:SARS-CoV-2 Spike (RBD) Inhibitor Screening Colorimetric Assay Kit is designed for screening and profiling inhibitors of this interaction. The key to this kit is the high sensitivity of detection of Fc-tagged Spike protein by HRP-labeled Anti-mouse-Fc. Only a few simple steps on a microtiter plate are required for the assay. First, ACE2 protein is attached to a clear nickel-coated 96-well plate. Next, SARS-CoV-2 Spike-Fc is incubated with ACE2 on the plate. Finally, the plate is treated with HRP-labeled anti-Fc, followed by addition of an HRP substrate to produce color, which can then be measured using a UV/Vis spectrophotometer microplate reader. |
Tubulin inhibitor 19 |
T61459-10mg |
TargetMol Chemicals |
10mg |
Ask for price |
|
Description: Tubulin inhibitor 19 |